Structural and Functional Evolution of Human Immunodeficiency Virus Type 1 Long Terminal Repeat CCAAT/Enhancer Binding Protein Sites and Their Use as Molecular Markers for Central Nervous System Disease Progression

References

• Ait-Khaled M, Emery VC (1994). Phylogenetic relation-ship between human immunodeficiency virus type 1 (HIV-1) long terminal repeat natural variants present in the lymph node and peripheral blood of three HIV-1-infected individuals. J Gen Virol 75: 1615–1621.
   Google Scholar
• Ait-Khaled M, McLaughlin JE, Johnson MA, Emery VC (1995). Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient. AIDS 9: 675–683.
   PubMed Web of Science ®Google Scholar
• Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T (1990). A nu-clear factor for IL-6 expression (NF-1L6) is a member of a C/EBP family. EMBO J9: 1897–1906.
   Google Scholar
• Asjo B, Morfeldt-Manson L, Albert J, Biberfeld G, Karlsson A, Lidman K, Fenyo EM (1986). Replicative ca-pacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 2: 660–662.
   Google Scholar
• Berkhout B, Jeang KT (1992). Functional roles for the TATA promoter and enhancers in basal and Tat-induced ex-pression of the human immunodeficiency virus type 1 long terminal repeat. J Virol 66: 139–149.
   PubMed Web of Science ®Google Scholar
• Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL (1989). Tissue-specific expression, developmental regulation, and genetic map-ping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 3: 1146–1156.
   PubMed Web of Science ®Google Scholar
• Blankson JN, Persaud D, Siliciano RF (2002). The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 53: 557–593.
   PubMed Web of Science ®Google Scholar
• Bretz JD, Williams SC, Baer M, Johnson PF, Schwartz RC (1994). C/EBP-related protein 2 confers lipopoly-saccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. Proc Nati Acad Sci USA 91: 7306–7310.
   PubMedGoogle Scholar
• Bronstein I, Voyta JC, Murphy OJ, Bresnick L, Kricka LJ (1992). Improved chemiluminescent western blotting procedure. Biotechniques 12: 748–753.
   Google Scholar
• Bumette WN (1981). "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodi-nated protein A. Anal Biochem 112: 195–203.
   PubMed Web of Science ®Google Scholar
• Chang CJ, Chen TT, Lei HY, Chen DS, Lee SC (1990). Molec-ular cloning of a transcription factor, AGP/EBP, that be-longs to members of the C/EBP family. Mol Cell Bio110: 6642–6653.
   Google Scholar
• Corboy JR, Buzy JM, Zink MC, Clements JE (1992). Ex-pression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258: 1804–1808.
   PubMed Web of Science ®Google Scholar
• Delassus S, Cheynier R, Wain-Hobson S (1991). Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J Virol 65: 225–231.
   Google Scholar
• Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U (1990). LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional ac-tivator protein. Genes Dev 4: 1541–1551.
   PubMedGoogle Scholar
• Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ (1996). Human immun-odeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection dis-play a wide range of sequence polymorphism and tran-scription activity. J Virol 70: 4053–4062.
   PubMed Web of Science ®Google Scholar
• Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, Richardson MW, Amini S, Morgello S, Khalili K, Rappaport J (2001). CNS invasion by CD14±/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reser-voir of HIV infection. J NeuroVirol 7: 528–541.
   PubMed Web of Science ®Google Scholar
• Gartner S, Liu Y (2002). Insights into the role of immune activation in HIV neuropathogenesis.J NeuroVirol 8: 69–75.
   PubMed Web of Science ®Google Scholar
• Gartner S, Markovits P, Markovitz DM, Betts RF, Popovic M (1986). Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 256: 2365–2371.
   Google Scholar
• Gendelman HE, Orenstein JM, Baca LM, Weiser B, Burger H, Kalter DC, Meltzer MS (1989). The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3: 475–495.
   PubMed Web of Science ®Google Scholar
• Gillespie PG, Hudspeth AJ (1991). Chemiluminescence de-tection of proteins from single cells. Proc Nati Acad Sci USA 88: 2563–2567.
   PubMedGoogle Scholar
• Golub El, Li GG, Volsky DJ (1990). Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human im-munodeficiency virus type 1 isolates. J Virol 64: 3654–3660.
   Google Scholar
• Goodenow M, Huet T, Saurin W, Kwok S, Sninsky J, Wain-Hobson S (1989). HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr 2: 344–352.
   PubMedGoogle Scholar
• Gowda SD, Stein BS, Mohagheghpour N, Benike CJ, Engleman EG (1989). Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Im-munol 142: 773–780.
   PubMed Web of Science ®Google Scholar
• Henderson AJ, Calame KL (1997). CCAAT/enhancer bind-ing protein (C/EBP) sites are required for HIV-1 repli-cation in primary macrophages but not CD4(±) T cells. Proc Nati Acad Sci USA 94: 8714–8719.
   PubMed Web of Science ®Google Scholar
• Henderson AJ, Connor RI, Calame KL (1996). C/EBP acti-vators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5: 91–101.
   PubMed Web of Science ®Google Scholar
• Henderson AJ, Zou X, Calame KL (1995). C/EBP pro-teins activate transcription from the human immun-odeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 69: 5337–5344.
   PubMed Web of Science ®Google Scholar
• Hirsch I, Spire B, Tsunetsugu-Yokota Y, Neuveut C, Sire J, Chermann JC (1990). Differences in replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) are not determined by long terminal re-peats (LTR). Virology 177: 759–763.
   Google Scholar
• Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995). Rapid turnover of plasma viri-ons and CD4 lymphocytes in HIV-1 infection [see com-ments]. Nature 373: 123–126.
   Google Scholar
• Hogan TH, Nonnemacher MR, Krebs FC, Henderson A, Wigdahl B (2003). HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed Pharmacother In press.
   Google Scholar
• Kassa E, Rinke de Wit TF, Hailu E, Girma M, Messele T, Mariam HG, Yohannes S, Jurriaans S, Yeneneh H, Coutinho RA, Fontanet AL (1999). Evaluation of the World Health Organization staging system for HIV infec-tion and disease in Ethiopia: association between clini-cal stages and laboratory markers. AIDS 13: 381–389.
   PubMed Web of Science ®Google Scholar
• Kirchhoff F, Greenough TC, Hamacher M, Sullivan JL, Desrosiers RC (1997). Activity of human immunodefi-ciency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. Virology 232: 319–331.
   Google Scholar
• Krebs FC, Goodenow MM, Wigdahl B (1997). Neuroglial ATF/CREB factors interact with the human immunode-ficiency virus type 1 long terminal repeat. J NeuroVirol 3\(Suppl 1): S28–S32.
   Google Scholar
• Krebs FC, Hogan TH, Quiterio SJ, Gartner S, Wigdahl B (2001). Lentiviral LTR-directed expression, sequence variation, and disease pathogenesis. In: HIV Sequence Compendium 2001. Kuiken CL, Foley B, Hahn B, Korber B, McCutchan F, Marx PA, Mellors JW, Sodroski J, Wolinksy S (eds). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory: Los Alamos, NM, pp 1–42.
   Google Scholar
• Krebs FC, Mehrens D, Pomeroy S, Goodenow MM, Wigdahl B (1998). Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. jBiomed Sci 5: 31–44.
   Google Scholar
• Krebs FC, Ross H, McAllister J, Wigdahl B (2000). HIV-1-associated central nervous system dysfunction. Adv Pharmacol 49: 315–385.
   Google Scholar
• Lee YH, Williams SC, Baer M, Sterneck E, Gonzalez FJ, Johnson PF (1997). The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 protein is spec-ified by the leucine zipper and activation domain. Mol Cell Bio117: 2038–2047.
   Google Scholar
• Levy JA (1993). Pathogenesis of human immunodeficiency virus infection. Microbic)] Rev 57: 183–289.
   PubMedGoogle Scholar
• Liu Y, Tang XP, McArthur JC, Scott J, Gartner S (2000). Anal-ysis of human immunodeficiency virus type 1 gp160 se-quences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J NeuroVirol 6\(Suppl 1): S70–S81.
   Google Scholar
• Martin JC, Bandres JC (1999). Cells of the monocyte-macrophage lineage and pathogenesis of HIV-1 infec-tion. J Acquir Immune Defic Syndr 22: 413–429.
   PubMed Web of Science ®Google Scholar
• Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S (1993). Transcrip-tion factors NF-1L6 and NF-kappa B synergistically acti-vate transcription of the inflammatory cytokines, inter-leukin 6 and interleukin 8. Proc Nati Acad Sci USA 90: 10193–10197.
   PubMed Web of Science ®Google Scholar
• McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B (2000). Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. Virology 274: 262–277.
   Google Scholar
• McDougal JS, Mawle A, Cort SP, Nicholson JK, Cross GD, Scheppler-Campbell JA, Hicks D, Sligh J (1985). Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immuno1135: 3151–3162.
   Google Scholar
• Michael NL, D'Arcy L, Ehrenberg PK, Redfield RR (1994). Naturally occurring genotypes of the human immunode-ficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J Virol 68: 3163–3174.
   Google Scholar
• Naghavi MH, Schwartz S, Sonnerborg A, Vahlne A (1999). Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res Hum Retro-viruses 15: 1293–1303.
   Google Scholar
• Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS (1993). HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease [see com-ments]. Nature 362: 355–358.
   PubMed Web of Science ®Google Scholar
• Pomerantz RJ, Feinberg MB, Andino R, Baltimore D (1991). The long terminal repeat is not a major determinant of the cellular tropism of human immunodeficiency virus type 1.J Virol 65: 1041–1045.
   Google Scholar
• Pope RM, Leutz A, Ness SA (1994). C/EBP beta regulation of the tumor necrosis factor alpha gene. J Clin Invest 94: 1449–1455.
   PubMed Web of Science ®Google Scholar
• Quinones-Mateu ME, Mas A, Lain de Lera T, Soriano V, Alcami J, Lederman MM, Domingo E (1998). LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Virus Res 57: 11–20.
   Google Scholar
• Rodenburg CM, Li Y, Trask SA, Chen Y, Decker J, Robertson DL, Kalish ML, Shaw GM, Allen S, Hahn BH, Gao F (2001). Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses 17: 161–168.
   PubMed Web of Science ®Google Scholar
• Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B (2001a). HIV-1 LTR C/EBP binding site sequence configurations preferentially en-countered in brain lead to enhanced C/EBP factor bind-ing and increased LTR-specific activity. J NeuroVirol 7: 235–249.
   PubMed Web of Science ®Google Scholar
• Ross HL, Nonnemacher MR, Hogan TH, Quiterio SJ, Henderson A, McAllister JJ, Krebs FC, Wigdahl B (2001b). Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding pro-tein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lin-eage. J Virol 75: 1842–1856.
   PubMedGoogle Scholar
• Rousseau C, Abrams E, Lee M, Urbano R, King MC (1997). Long terminal repeat and nef gene variants of human immunodeficiency virus type 1 in perinatally infected long-term survivors and rapid progressors. AIDS Res Hum Retroviruses 13: 1611–1623.
   Google Scholar
• Sandhu GS, Eckloff BW, Kline BC (1991). Chemilumines-cent substrates increase sensitivity of antigen detection in western blots. Biotechniques 11: 14–16.
   PubMedGoogle Scholar
• Schuitemaker H, Groenink M, Meyaard L, Kootstra NA, Fouchier RA, Gruters RA, Huisman HG, Tersmette M, Miedema F (1993). Early replication steps but not cell type-specific signalling of the viral long terminal re-peat determine HIV-1 monocytotropism. AIDS Res Hum Retroviruses 9: 669–675.
   Google Scholar
• Stein B, Baldwin AS, Jr (1993). Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol Cell Bio113: 7191–7198.
   Google Scholar
• Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T (1995). Targeted disruption of the NF-1L6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80: 353–361.
   PubMed Web of Science ®Google Scholar
• Tesmer VM, Rajadhyaksha A, Babin J, Bina M (1993). NF-1L6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90: 7298–7302.
   Google Scholar
• Vallejo M, Ron D, Miller CP, Habener JF (1993). C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP re-sponse elements. Proc Nati Acad Sci USA 90: 4679–4683.
   PubMedGoogle Scholar
• Velpandi A, Nagashunmugam T, Otsuka T, Cartas M, Srinivasan A (1992). Structure-function studies of HIV-1: influence of long terminal repeat U3 region seque-nces on virus production. DNA Cell Bio111: 369–376.
   Google Scholar
• Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, et al (1995). Viral dynamics in human immunode-ficiency virus type 1 infection. Nature 373: 117–122.
   PubMed Web of Science ®Google Scholar
• Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, Alvarez X, Lackner AA (2001). Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193: 905–915.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) (1993). Proposed 'World Health Organization staging system for HIV infection and disease': preliminary testing by an international col-laborative cross-sectional study. The WHO International Collaborating Group for the Study of the WHO Staging System. AIDS 7: 711–718.
   Google Scholar
• Zhang L, Huang Y, Yuan H, Chen BK, Ip J, Ho DD (1997). Genotypic and phenotypic characterization of long ter-minal repeat sequences from long-term survivors of hu-man immunodeficiency virus type 1 infection. J Virol 71: 5608–5613.
   Google Scholar